CompletedNot Applicable

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

Egypt100 participantsStarted 2023-12-01

Plain-language summary

The purpose of this study is to compare the use of the progesterone-primed ovarian stimulation protocol versus GnRH antagonist protocol in women with polycystic ovarian syndrome (PCOS) regarding the number of oocytes retrieved, percentage of MII oocytes, and the rate of good quality blastocysts available for cryopreservation.

Who can participate

Age range37 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Female age \<37 years.
✓. Body mass index (BMI) between (≥18 kg/m2 and ≤35 kg/m2).
✓. Polycystic ovarian syndrome patients (according to Rotterdam criteria).
✓. Patients suffering from primary or secondary infertility who are candidates for ICSI.

Exclusion criteria

✕. Uncorrected Uterine factor of infertility: intrauterine adhesions, submucosal fibroids, and septate uterus.
✕. Severe male factor infertility

What they're measuring

Number of oocytes retrieved (ovarian response).

Timeframe: Baseline

Percentage of MII oocytes.

Timeframe: Baseline

Rate of good-quality blastocysts available for cryopreservation

Timeframe: Baseline

Trial details

NCT IDNCT06812559

SponsorEl Shatby University Hospital for Obstetrics and Gynecology

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-02-01

View on ClinicalTrials.gov More Controlled Ovarian Hyperstimulation trials